Help
Subscribe


GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy

 19 November 2017

Advanced search
GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy Profile of Roy Pounder

Home

News  
Journals
Review Articles
Slide Atlas
Video Clips
Online Books
Advanced Digestive Endoscopy
Classical Cases
Conference Diary
PubMed
International GH Links
USA GH Links
National GH Links
National GI Societies
Other Useful Links




Emails on Gastroenterology and Hepatology
the National AIDS Treatment Advocacy Project
Visit the gastroenterology section of the EUMS

News

Support for colorectal cancer screening with sigmoidoscopy

Early results of a randomized controlled trial in this week's issue of the Lancet suggest that a single flexible sigmoidoscopy screening program, offered at around age 60 years, could lower the incidence and mortality of colorectal cancer.

News image

fiogf49gjkf04

Around 16,000 people die from colorectal cancer in the UK every year, with annual health-care costs for treatment of the disease estimated at £300 million.

Survival rates exceed 90% if the disease is detected at an early stage; population screening is feasible as most invasive tumors develop slowly from non-cancerous polyps.

In the UK, flexible sigmoidoscopy is judged a more suitable tool for population screening than colonoscopy (advocated in the USA), because it is safer, cheaper, quicker, and more convenient. In addition, uptake rates are much higher.

Two thirds of adenomas and cancers are located in the rectum and sigmoid colon, which is within reach of the flexible sigmoidoscope, and the procedure takes only 5 minutes.

Wendy Atkin and colleagues from Cancer Research UK led the trial.

Men and women aged 55-64 years from 14 UK centers were randomly assigned screening or control (ratio 1:2). The control group was not contacted.

Small polyps were removed during screening, and individuals were referred for colonoscopy if high-risk polyps were found.

Around 170,000 individuals were randomized. Attendance among those assigned screening was 71%.

Some 2131 (5%) patients were classified as high-risk and referred for colonoscopy; 38,525 (95%) with no polyps or only low-risk polyps detected were discharged.

There was 1 perforation in 40,000 flexible sigmoidoscopy examinations, compared with 4 perforations among 2377 patients given colonoscopy.

Perforation was 100-times more likely with colonoscopy than sigmoidoscopy.
Lancet

An average of 48 people were screened, and 2 or 3 colonoscopy referrals generated, per center each week.

In an accompanying Commentary, David Ransohoff from the University of North Carolina, USA, comments, "The UK investigators raise provocative questions about the approach of tailoring not only work-up and surveillance, but also screening itself.

"For example, by suggesting once-in-a-lifetime screening sigmoidoscopy, or by suggesting that some subgroups have such a low risk of proximal colorectal cancer, that sigmoidoscopy alone may be a quite adequate test."

"Implementation of a tailored approach, by adjusting intensity of screening or surveillance to a person's risk, requires consideration of three points.

"These are the individual's absolute risk of colorectal cancer, the degree to which each screening or surveillance strategy reduces that risk, and quantitative definition of the goals of screening (i.e. what level of absolute risk is high enough to justify the effort of reduction)," he adds.

"By contrast, a one-size-fits-all approach to screening and surveillance may be easier to implement, but less efficient.

"In some cases - for example, when people with very low risk of subsequent colorectal cancer undergo potentially hazardous surveillance procedures such as colonoscopy - such an approach may even be harmful.

"A tailored approach, based on a quantitative definition of the goals of screening and surveillance, deserves increased consideration."

"Further reports from the UK trial and its USA counterpart will help guide the design and implementation of screening programs to reduce deaths from colorectal cancer, " he concludes.

Lancet 2002; 359(9314): 1266, 1291
12 April 2002

Go to top of page Email this page Email this page to a colleague

 17 November 2017 
Food elimination diets for treatment of adults with eosinophilic esophagitis
 17 November 2017 
PPI use and cognitive function in women
 17 November 2017 
Predicting microscopic colitis
 16 November 2017 
NAFLD-hepatocellular carcinoma and survival after orthotopic liver transplant
 16 November 2017 
Prepregnancy obesity and severe maternal morbidity
 16 November 2017 
Celiac disease screening in adult first-degree relatives
 15 November 2017 
Breastfeeding and the risk of IBD
 15 November 2017 
Medication nonadherence and health care costs
 15 November 2017 
Predicting recurrence after curative rectal cancer surgery
 14 November 2017 
HBV/HCV coinfection and cirrhosis
 14 November 2017 
Sexual dysfunction after rectal cancer surgery
 14 November 2017 
Eosinophilic gastroenteritis and colitis
 13 November 2017 
GI bleeding in patients taking non–vitamin K antagonist oral anticoagulants
 13 November 2017 
Genetic polymorphisms, fatty acids and ulcerative colitis
 13 November 2017 
Flares after immunomodulator withdrawal in Crohn's
 10 November 2017 
Thiopurines vs TNF and lymphoma risk in IBD
 10 November 2017 
Drug monitoring of anti-tumour necrosis factor therapy in IBD
 10 November 2017 
Treatment decisions for older patients with colorectal cancer
 09 November 2017 
Quality standards in upper gastrointestinal endoscopy
 09 November 2017 
Irradiated rectal cancer and chemoradiotherapy
 09 November 2017 
Environmental factors and IBD
 08 November 2017 
Prophylaxis of spontaneous bacterial peritonitis
 08 November 2017 
Socioeconomic characteristics in diverticular disease
 08 November 2017 
Optimal management of postoperative Crohn's disease
 07 November 2017 
Community Screening for Helicobacter pylori
 07 November 2017 
Early readmission in IBD patients
 07 November 2017 
Mesocolic excision for colon cancer
 06 November 2017 
Food elimination diet for children with eosinophilic esophagitis
 06 November 2017 
Biologic agents and obesity in children with IBD
 06 November 2017 
Liver cancer burden despite extensive use of antiviral agents
 03 November 2017 
Statins and mortality in chronic viral hepatitis
 03 November 2017 
Propofol for outpatient colonoscopy
 03 November 2017 
Asthma and IBD development
 02 November 2017 
Diverticulitis and emergency department burden
 02 November 2017 
Rural residence and risk of IBD
 02 November 2017 
Sexual functioning in Hep C
 01 November 2017 
Heartburn relief in adolescents with GERD
 01 November 2017 
Barriers to hepatitis C treatment
 01 November 2017 
Autoimmune pancreatitis in children
 31 October 2017 
Surveillance in ulcerative colitis and Crohn’s disease
 31 October 2017 
Endoscopic indices of disease activity for Crohn’s
 31 October 2017 
Follow-up of positive results on fecal blood tests
 30 October 2017 
Local recurrence after curative rectal cancer surgery
 30 October 2017 
Low-flow ascites pump in refractory cirrhosis
 30 October 2017 
Medical therapy of patients with pediatric-onset IBD
 27 October 2017 
NAFLD in advanced fibrosis in the USA
 27 October 2017 
Early readmission in cirrhosis after bacterial infections
 26 October 2017 
Predicting response to anti-TNF therapy in Crohn's
 26 October 2017 
Conversion to open laparotomy in rectal cancer
 25 October 2017 
Conversion of colonoscopy to sigmoidoscopy
 25 October 2017 
Fecal microbiota transplantation
 25 October 2017 
Rifaximin and survival in hepatic encephalopathy
 24 October 2017 
Eosinophilic esophagitis with swallowed topical corticosteroids
 24 October 2017 
Meta-analysis in nutritiona research
 23 October 2017 
NAFLD-related hepatocellular carcinoma in liver resection
 23 October 2017 
Outcome of hepatic sarcoidosis
 20 October 2017 
Hospital readmissions reduction program
 20 October 2017 
Conversion of planned colonoscopy to sigmoidoscopy
 19 October 2017 
Fecal immunochemical tests in colorectal cancer screening
 19 October 2017 
Current management of chylous ascites

Blackwell Publishing


GastroHep.com is a Blackwell Publishing registered trademark
© 2017 Wiley-Blackwell and GastroHep.com and contributors
Privacy Statement
Disclaimer
About Us